002550.SZ Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 09:04):

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China...

Stats
Dagens volum	22.99M
Gjennomsnittsvolum	12.36M
Markedsverdi	6.81B
EPS	CNY0.0618 ( 2023-10-24 )
Neste inntjeningsdato	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	33.38
ATR14	CNY0.0100 (0.19%)

Volum Korrelasjon

Lang: -0.12 (neutral)

Kort: -0.25 (neutral)

Signal:(37.392) Neutral

Changzhou Qianhong Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Changzhou Qianhong Korrelasjon - Valuta/Råvare

0.35
( neutral )

0.40
( neutral )

0.00
( neutral )

-0.13
( neutral )

-0.57
( weak negative )

Changzhou Qianhong Økonomi

Annual	2023
Omsetning:	CNY1.79B
Bruttogevinst:	CNY726.92M (40.52 %)
EPS:	CNY0.140

FY	2023
Omsetning:	CNY1.79B
Bruttogevinst:	CNY726.92M (40.52 %)
EPS:	CNY0.140

FY	2022
Omsetning:	CNY2.30B
Bruttogevinst:	CNY888.97M (38.59 %)
EPS:	CNY0.250

FY	2021
Omsetning:	CNY1.87B
Bruttogevinst:	CNY833.63M (44.46 %)
EPS:	CNY0.150

Financial Reports:

No articles found.

Changzhou Qianhong

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.